Bridgeway Capital Management, LLC Heron Therapeutics, Inc. Transaction History
Bridgeway Capital Management, LLC
- $4.38 Billion
- Q3 2025
A detailed history of Bridgeway Capital Management, LLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 700,000 shares of HRTX stock, worth $770,000. This represents 0.02% of its overall portfolio holdings.
Number of Shares
700,000
Previous 700,000
-0.0%
Holding current value
$770,000
Previous $1.45 Million
38.16%
% of portfolio
0.02%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding HRTX
# of Institutions
189Shares Held
151MCall Options Held
20.1KPut Options Held
2.12M-
Rubric Capital Management LP New York, NY29.1MShares$32 Million0.61% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA10.2MShares$11.3 Million0.02% of portfolio
-
Clearline Capital LP New York, NY9.71MShares$10.7 Million0.62% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA8.75MShares$9.63 Million21.67% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.46MShares$9.31 Million0.0% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $131M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...